Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of mRNAs encoding OX40L, IL-23 and IL-36gamma in combination with immune checkpoint blockade for treating particular cancers

Use of mRNAs encoding OX40L, IL-23 and IL-36gamma in combination with immune checkpoint blockade for treating particular cancers

US Patent 12042527 · Granted Jul 23, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Concatemeric peptide epitope RNAs2024
Liquid enhanced laser stripping2023
Liquid enhanced laser stripping2022
CHIKV RNA vaccines2022
HMPV/hPIV3 mRNA vaccine composition2022
Zika virus RNA vaccines2022
Chikungunya virus RNA vaccines2022
CHIKV RNA vaccines2020
Chikungunya virus RNA vaccines2020
Zika virus RNA vaccines2019
Zika RNA vaccines2019
Chikagunya virus RNA vaccines2019